Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.15 BRL | +0.41% | +2.45% | -11.51% |
04/03 | Barclays Downgrades Ambev to Equalweight From Overweight, Adjusts Price Target to $3 From $3.50 | MT |
29/02 | Transcript : Ambev S.A., Q4 2023 Earnings Call, Feb 29, 2024 |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- This company will be of major interest to investors in search of a high dividend stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Brewers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.51% | 36.95B | B- | ||
-4.72% | 119B | A- | ||
-1.35% | 55.14B | B+ | ||
+5.05% | 46.46B | C+ | ||
-1.76% | 22.83B | - | B+ | |
+9.28% | 18.96B | B | ||
-23.12% | 18.54B | B | ||
+3.25% | 17.45B | A- | ||
+5.41% | 14.93B | B- | ||
+9.73% | 12.78B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ABEV3 Stock
- Ratings Ambev S.A.